INTERNATIONAL PATENT: VERSANIS BIO, INC. FILES APPLICATION FOR "ACTRII ANTIBODIES WITH EXTENDED HALF LIFE"

GENEVA, Sept. 10 -- VERSANIS BIO, INC. (Lilly Corporate CenterIndianapolis, Indiana 46285) filed a patent application (PCT/US2025/016535) for "ACTRII ANTIBODIES WITH EXTENDED HALF LIFE" on Feb 20, 2025. With publication no. WO/2025/183966, the details related to the patent application was published on Sep 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KLICKSTEIN, Lloyd B. (c/o Versanis Bio, Inc.PO Box 6288Indianapolis, Indiana 46206-6288)

Abstract: Provided herein are ActRII antibodies exhibiting extended half-life. Also provided are methods of using such antibodies for the treatment...